Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 299, Issue 1, 2010, Pages

  Cherney, David Z I ^a   Reich, Heather N ^a   Miller, Judith A ^a   Lai, Vesta ^a   Zinman, Bernard ^b   Dekker, Maria G ^c   Bradley, Timothy J ^c   Scholey, James W ^a   Sochett, Etienne B ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MOUNT SINAI HOSPITAL   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Arterial stiffness; Renal hemodynamic function; Systemic blood pressure

Indexed keywords

ANGIOTENSIN II;

ADULT; AGE; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASOCONSTRICTION;

ADOLESCENT; ADULT; AGING; ANGIOTENSIN II; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HEMODYNAMICS; HUMANS; HYPERGLYCEMIA; KIDNEY; MALE; POLYURIA; RENAL PLASMA FLOW, EFFECTIVE; RENIN-ANGIOTENSIN SYSTEM; THIRST; VASCULAR RESISTANCE;

EID: 77954396754     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00027.2010     Document Type: Article

References (54)

1. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors, and growth factors/cytokines. Endocr Rev 25: 971-1010, 2004.
2. Brenner BM, Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA. The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy. Acta Endocrinol Suppl (Copenh) 242: 7-10, 1981.
3. Miller JA. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 10: 1778-1785, 1999.
4. Matsumoto N, Ishimura E, Taniwaki H, Emoto M, Shoji T, Kawagishi T, Inaba M, Nishizawa Y. Diabetes mellitus worsens intrarenal hemodynamic abnormalities in nondialyzed patients with chronic renal failure. Nephron 86: 44-51, 2000.
5. Nosadini R, Velussi M, Brocco E, Abaterusso C, Carraro A, Piarulli F, Morgia G, Satta A, Faedda R, Abhyankar A, Luthman H, Tonolo G. Increased renal arterial resistance predicts the course of renal function in type 2 diabetes with microalbuminuria. Diabetes 55: 234-239, 2006.
6. Vervoort G, Wetzels JF, Lutterman JA, van Doorn LG, Berden JH, Smits P. Elevated skeletal muscle blood flow in noncomplicated type 1 diabetes mellitus: role of nitric oxide and sympathetic tone. Hypertension 34: 1080-1085, 1999.
7. Dalla Vestra M, Sacerdoti D, Bombonato G, Fioretto P, Finucci G, Saller A, Sfriso A, Bruseghin M, Sambataro M, Velussi M, Baggio B, Nosadini R, Crepaldi G. Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes. Eur J Endocrinol 146: 687-694, 2002.
8. Ronnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH. Altered age-related blood pressure pattern in type 1 diabetes. Circulation 110: 1076-1082, 2004.
9. Herbert KE, Mistry Y, Hastings R, Poolman T, Niklason L, Williams B. Angiotensin II mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ Res 102: 201-208, 2008.
10. Kunieda T, Minamino T, Nishi J, Tateno K, Oyama T, Katsuno T, Miyauchi H, Orimo M, Okada S, Takamura M, Nagai T, Kaneko S, Komuro I. Angiotensin II induces premature senescence of vascular smooth muscle cells, and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 114: 953-960, 2006.
11. Sanada F, Taniyama Y, Azuma J, Iekushi K, Dosaka N, Yokoi T, Koibuchi N, Kusunoki H, Aizawa Y, Morishita R. Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence. Hypertension 53: 77-82, 2009.
12. Akbari CM, Saouaf R, Barnhill DF, Newman PA, LoGerfo FW, Veves A. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg 28: 687-694, 1998.
13. Gordin D, Ronnback M, Forsblom C, Heikkila O, Saraheimo M, Groop PH. Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes. Diabetologia 50: 1808-1814, 2007.
14. Wang M, Monticone RE, Lakatta EG. Arterial aging: a journey into subclinical arterial disease. Curr Opin Nephrol Hypertens 19: 201-207.
15. Wray DW, Nishiyama SK, Harris RA, Richardson RS. Angiotensin II in the elderly: impact of angiotensin II type 1 receptor sensitivity on peripheral hemodynamics. Hypertension 51: 1611-1616, 2008.
16. Ishii M, Ohno K. Comparisons of body fluid volumes, plasma renin activity, hemodynamics, and pressor responsiveness between juvenile and aged patients with essential hypertension. Jpn Circ J 41: 237-246, 1977. (Pubitemid 8113599)
17. Schram MT, Schalkwijk CG, Bootsma AH, Fuller JH, Chaturvedi N, Stehouwer CD. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension 46: 232-237, 2005.
18. Holl RW, Pavlovic M, Heinze E, Thon A. Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care 22: 1151-1157, 1999.
19. Mauer M, Drummond K. The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. Diabetes 51: 1572-1579, 2002. (Pubitemid 34826627)
20. Miller JA, Anacta LA, Cattran DC. Impact of gender on the renal response to angiotensin II. Kidney Int 55: 278-285, 1999.
21. Miller JA, Cherney DZ, Duncan JA, Lai V, Burns KD, Kennedy CR, Zimpelmann J, Gao W, Cattran DC, Scholey JW. Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol 17: 2554-2560, 2006.
22. Ahmed SB, Kang AK, Burns KD, Kennedy CR, Lai V, Cattran DC, Scholey JW, Miller JA. Effects of oral contraceptive use on the renal and systemic vascular response to angiotensin II infusion. J Am Soc Nephrol 15: 780-786, 2004.
23. Cherney DZ, Scholey JW, Nasrallah R, Dekker MG, Slorach C, Bradley TJ, Hebert RL, Sochett EB, Miller JA. Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus. Am J Physiol Renal Physiol 294: F1336-F1341, 2008.
24. Mustata S, Chan C, Lai V, Miller JA. Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients. J Am Soc Nephrol 15: 2713-2718, 2004.
25. Cherney DZ, Lai V, Scholey JW, Miller JA, Zinman B, Reich HN. The effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes mellitus: a pilot study. Diabetes Care 33: 361-365, 2010.
26. Campbell WR, Hanna MI. The estimation of fructose, sucrose, and inulin. J Biol Chem: 703-711, 1926.
27. Cherney DZ, Sochett EB, Miller JA. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 68: 1722-1728, 2005.
28. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12: 1211-1217, 2001.
29. Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK. Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension 46: 1316-1320, 2005.
30. Minamino T, Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res 100: 15-26, 2007.
31. 1 receptor expression and potentiate ANG II-induced proliferation in VSM cells. Am J Physiol Heart Circ Physiol 284: H846-H852, 2003.
32. 1 receptor. J Cell Physiol 215: 374-382, 2008.
33. Pannier BM, Guerin AP, Marchais SJ, London GM. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension. Clin Exp Pharmacol Physiol 28: 1074-1077, 2001.
34. Mitchell GF, Izzo JL Jr, Lacourciere Y, Ouellet JP, Neutel J, Qian C, Kerwin LJ, Block AJ, Pfeffer MA. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation 105: 2955-2961, 2002.
35. Asmar R. Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: clinical implications. Am J Cardiovasc Drugs 1: 387-397, 2001.
36. Xu ZG, Miao LN, Cui YC, Jia Y, Yuan H, Wu M. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli. Nephrol Dial Transplant 24: 1744-1752, 2009.
37. Michels LD, O'Donnell MP, Keane WF. Glomerular hemodynamic and structural correlations in long-term experimental diabetic rats. J Lab Clin Med 103: 840-847, 1984.
38. Scaramuzza A, Salvucci F, Leuzzi S, Radaelli A, d'Annunzio G, Fratino P, Lorini R, Bernardi L. Cardiovascular autonomic testing in adolescents with type I (insulin-dependent) diabetes mellitus: an 18-month follow-up study. Clin Sci (Lond) 94: 615-621, 1998.
39. Price DA, Porter LE, Gordon M, Fisher ND, De'Oliveira JM, Laffel LM, Passan DR, Williams GH, Hollenberg NK. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 10: 2382-2391, 1999.
40. Schalekamp MA, Krauss XH, Schalekamp-Kuyken MP, Kolsters G, Birkenhager WH. Studies on the mechanism of hypernatriuresis in essential hypertension in relation to measurements of plasma renin concentration, body fluid compartments, and renal function. Clin Sci 41: 219-231, 1971.
41. Hayduk K, Krause DK, Kaufmann W, Huenges R, Schillmoller U, Umbehaun V. Age-dependent changes of plasma renin concentration in humans. Clin Sci Mol Med Suppl 45 Suppl 1: 273s-278s, 1973.
42. Thomas GW, Ledingham JG, Beilin LJ, Stott AN. Reduced plasma renin activity in essential hypertension: effects of blood pressure, age, and sodium. Clin Sci Mol Med Suppl 3: 185s-188s, 1976.
43. James GD, Sealey JE, Muller F, Alderman M, Madhavan S, Laragh JH. Renin relationship to sex, race, and age in a normotensive population. J Hypertens Suppl 4: S387-389, 1986. (Pubitemid 17054558)
44. Gordon R, Doran F, Thomas M, Thomas F, Cheras P. Solitary kidney and ageing as causes of low renin and aldosterone concentrations: relevance to "low-renin" essential hypertension. Clin Sci Mol Med Suppl 3: 177s-180s, 1976.
45. Nami R, Martinelli M, Panza F, Pavese G, Carletti F, Buracchi P, Lucani B, Pazzaglia A, Saia F, Gennari C. [Age-related changes in the renin-angiotensin-aldosterone system and the sympathetic nervous system in patients with essential hypertension]. Minerva Cardioangiol 41: 387-395, 1993.
46. Laitinen T, Hartikainen J, Vanninen E, Niskanen L, Geelen G, Lansimies E. Age and gender dependency of baroreflex sensitivity in healthy subjects. J Appl Physiol 84: 576-583, 1998. (Pubitemid 28081111)
47. Weidmann P, De Myttenaere-Bursztein S, Maxwell MH, de Lima J. Effect on aging on plasma renin and aldosterone in normal man. Kidney Int 8: 325-333, 1975.
48. Padfield PL, Brown JJ, Lever AF, Schalekamp MA, Beevers DG, Davies DL, Robertson JI, Tree M. Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Lancet 1: 548-550, 1975.
49. Tuck ML, Williams GH, Cain JP, Sullivan JM, Dluhy RG. Relation of age, diastolic pressure, and known duration of hypertension to presence of low renin essential hypertension. Am J Cardiol 32: 637-642, 1973.
50. Parving HH, Hommel E, Mathiesen E, Skott P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E. Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 296: 156-160, 1988.
51. Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE, Drash AL. Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 12: 686-693, 1989.
52. Drummond KN, Kramer MS, Suissa S, Levy-Marchal C, Dell'Aniello S, Sinaiko A, Mauer M. Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes 52: 1818-1824, 2003.
53. Kobayashi T, Nogami T, Taguchi K, Matsumoto T, Kamata K. Diabetic state, high plasma insulin, and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK. Br J Pharmacol 155: 974-983, 2008.
54. Arima S, Ito S, Omata K, Takeuchi K, Abe K. High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles. Kidney Int 48: 683-689, 1995.